Kinesin spindle protein inhibitor HR22C16 sensitizes TRAIL-induced apoptosis in human lung cancer H1299 cells

Bulletin of the Korean Chemical Society

Volumn 32, Issue 5, 2011, Pages 1737-1740

  Hwang, Mi Kyung ^a   Min, Yong Ki ^a   Kim, Seong Hwan ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

HR22C16; Kinesin spindle protein; Lung cancer; Sensitizer; TRAIL resistance

Indexed keywords

EID: 79957532424     PISSN: 02532964     EISSN: 12295949     Source Type: Journal    
DOI: 10.5012/bkcs.2011.32.5.1737     Document Type: Article

References (28)

1. (a) Pan, G.; O'Rourke, K.; Chinnaiyan, A. M.; Gentz, R.; Ebner, R.; Ni, J.; Dixit, V. M. Science 1997, 276, 111.
2. (b) Walczak, H.; Degli-Esposti, M. A.; Johnson, R. S.; Smolak, P. J.; Waugh, J. Y.; Boiani, N.; Timour, M. S.; Gerhart, M. J.; Schooley, K. A.; Smith, C. A.; Goodwin, R. G.; Rauch, C. T. EMBO J. 1997, 16, 5386.
3. Pennarun, B.; Meijer, A.; de Vries, E. G.; Kleibeuker, J. H.; Kruyt, F.; de Jong, S. Biochim. Biophys. Acta 2010, 1805, 123.
4. Cohen, G. M. Biochem. J. 1997, 326(Pt 1), 1.
5. Krueger, A.; Baumann, S.; Krammer, P. H.; Kirchhoff, S. Mol. Cell Biol. 2001, 21, 8247.
6. Walczak, H.; Miller, R. E.; Ariail, K.; Gliniak, B.; Griffith, T. S.; Kubin, M.; Chin, W.; Jones, J.; Woodward, A.; Le, T.; Smith, C.; Smolak, P.; Goodwin, R. G.; Rauch, C. T.; Schuh, J. C.; Lynch, D. H. Nat. Med. 1999, 5, 157.
7. Hotha, S.; Yarrow, J. C.; Yang, J. G.; Garrett, S.; Renduchintala, K. V.; Mayer, T. U.; Kapoor, T. M. Angew. Chem. Int. ed. Engl. 2003, 42, 2379.
8. (a) Tao, W.; South, V. J.; Zhang, Y.; Davide, J. P.; Farrell, L.; Kohl, N. E.; Sepp-Lorenzino, L.; Lobell, R. B. Cancer Cell 2005, 8, 49.
9. (b) Dagenbach, E. M.; Endow, S. A. J. Cell Sci. 2004, 117(Pt 1), 3.
10. (a) Vijapurkar, U.; Wang, W.; Herbst, R. Cancer Res. 2007, 67, 237.
11. (b) Kapoor, T. M.; Mayer, T. U.; Coughlin, M. L.; Mitchison, T. J. J. Cell Biol. 2000, 150, 975.
12. Miglarese, M. R.; Carlson, R. O. Expert Opin. Investig. Drugs 2006, 15, 1411.
13. LeBlanc, H. N.; Ashkenazi, A. Cell Death Differ. 2003, 10, 66.
14. Zhang, L.; Fang, B. Cancer Gene Ther. 2005, 12, 228.
15. Chawla-Sarkar, M.; Bae, S. I.; Reu, F. J.; Jacobs, B. S.; Lindner, D. J.; Borden, E. C. Cell Death Differ. 2004, 11, 915.
16. (a) Ng, C. P.; Bonavida, B. Mol. Cancer Ther. 2002, 1, 1051.
17. (b) Ng, C. P.; Zisman, A.; Bonavida, B. Prostate 2002, 53, 286.
18. Shi, J.; Orth, J. D.; Mitchison, T. Cancer Res. 2008, 68, 3269.
19. Altieri, D. C. Nat. Rev. Cancer 2003, 3, 46.
20. Adams, R. R.; Carmena, M.; Earnshaw, W. C. Trends Cell Biol. 2001, 11, 49.
21. Yang, D.; Welm, A.; Bishop, J. M. Proc. Natl. Acad. Sci. USA 2004, 101, 15100.
22. Fulda, S.; Meyer, E.; Debatin, K. M. Oncogene 2002, 21, 2283.
23. (a) Lee, K. Y.; Park, J. S.; Jee, Y. K.; Rosen, G. D. Exp. Mol. Med. 2002, 34, 462.
24. (b) Moon, D. O.; Kim, M. O.; Choi, Y. H.; Kim, G. Y. Mol. Cancer Ther. 2010, 9, 1583.
25. (c) Lirdprapamongkol, K.; Sakurai, H.; Suzuki, S.; Koizumi, K.; Prangsaengtong, O.; Viriyaroj, A.; Ruchirawat, S.; Svasti, J.; Saiki, I. In Vivo 2010, 24, 501.
26. (d) Jane, E. P.; Premkumar, D. R.; Pollack I. F. Mol. Cancer Ther. 2011, 10, 198.
27. Hwang, M. K.; Min, Y. K.; Kim, S. H. Biochem. Cell Biol. 2009, 87, 919.
28. Lee, S. U.; Choi, Y. H.; Kim, Y. S.; Min, Y. K.; Rhee, M.; Kim, S. H. Int. Immunopharmacol. 2010, 10, 298.